HMGCR and pulmonary arterial hypertension: Inhibition of HMG-CoA reductase (3-hydroxy-3-methyl-glutaryl-CoA) by statins is an established treatment for the prevention of cardiovascular disease, and has recently been found to improve exercise capacity in chronic obstructive pulmonary disease patients with pulmonary hypertension 25.